SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 125 filers reported holding SUTRO BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $4,192,000 | -24.7% | 281,702 | -4.5% | 0.46% | -1.5% |
| Q3 2021 | $5,569,000 | +1.6% | 294,825 | 0.0% | 0.47% | +26.1% |
| Q2 2021 | $5,481,000 | -18.3% | 294,825 | 0.0% | 0.37% | -28.0% |
| Q1 2021 | $6,710,000 | +53.3% | 294,825 | +46.2% | 0.52% | +32.7% |
| Q4 2020 | $4,377,000 | +14.0% | 201,600 | -52.3% | 0.39% | -34.6% |
| Q3 2019 | $3,841,000 | -24.3% | 422,589 | -5.2% | 0.59% | -14.6% |
| Q2 2019 | $5,074,000 | +1.7% | 445,889 | +1.8% | 0.69% | +52.5% |
| Q1 2019 | $4,988,000 | +35.6% | 437,889 | +7.4% | 0.46% | +9.6% |
| Q4 2018 | $3,679,000 | -10.8% | 407,889 | +48.3% | 0.42% | -12.4% |
| Q3 2018 | $4,125,000 | – | 275,000 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |